Atlas Trials

SMA

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch SMA

RecordFirmDate
A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy (NCT05337553)Biohaven Pharmaceuticals, Inc.2022-07-06
Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam (NCT05156320)Scholar Rock, Inc.2022-04-14
Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi (NCT04042025)Novartis Gene Therapies2020-02-10
An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy (NCT03921528)Scholar Rock, Inc.2019-04-22
Single-Dose Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1 (NCT03461289)Novartis Gene Therapies2018-08-16
Swiss Registry for Neuromuscular Disorders (NCT05102916)University of Bern2018-06-20
Hyperkinetic Movements in Patients With Disease of Motor Neurons and Their Response to Treatment With Nusinersen (NCT04825119)University Medical Centre Ljubljana2017-10-01
UK SMA Patient Registry (NCT04292574)Newcastle University2008-07-13
Study to Evaluate the Efficacy of Riluzole in Children and Young Adults With Spinal Muscular Atrophy (SMA) (NCT00774423)Assistance Publique - Hôpitaux de Paris2006-01-01
EAP of Apitegromab for Patients With Spinal Muscular Atrophy (NCT06877689)Scholar Rock, Inc.

Track SMA automatically

Every clearance here is in the API, with alerts when new ones post.